| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 10/06/2005 | WO2005023850A3 Method for producing inosine and 5'-inosinic acid by fermentation using bacterium belonging to the genus escherichia |
| 10/06/2005 | US20050222426 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine. |
| 10/06/2005 | US20050221489 Recombinant negative strand virus rna expression systems and vaccines |
| 10/06/2005 | US20050221466 Alanine 2,3,aminomutase |
| 10/06/2005 | US20050221447 Mannosyl transfer with regeneration of GDP-mannose |
| 10/06/2005 | US20050221428 Chimeric neuropeptide Y receptors |
| 10/06/2005 | US20050220958 Pasteurisation process for microbial cells and microbial oil |
| 10/06/2005 | US20050220819 Novel binding epitopes for helicobacter pylori and use thereof |
| 10/06/2005 | US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines |
| 10/06/2005 | US20050220776 Lactobacillus strains |
| 10/05/2005 | EP1582584A1 PROCESS FOR PRODUCING PNPase |
| 10/05/2005 | CN1676607A Cloning genes from streptomyces cyaneogriseus subsp. noncyanogenus for biosynthesis of antibiotics and methods of use |
| 10/05/2005 | CN1676599A Crystal purple salmonella culture medium |
| 10/05/2005 | CN1221665C Use of negative regulation elements for nerve-specific expression of transgenes |
| 10/05/2005 | CN1221569C Cell surface molecule mediating cell adhesion and signal transmission |
| 10/05/2005 | CN1221566C gClq receptor jointed HIV-lgp120 relative peptide and coded oligonucleotide thereof |
| 10/04/2005 | US6951922 Antibodies immunologically reactive with broad-spectrum delta endotoxins |
| 10/04/2005 | US6951756 Closure of bacterial ghost |
| 10/04/2005 | US6951744 Nucleotide sequence amplification; obtain nucleotide sequences, incubate with reaction mixture, digest with pyrophosphatase, amplify nucleotide sequences |
| 10/04/2005 | US6951742 Polyclonal and monoclonal antibodies to antigens in poultry or birds, formed using polynucleotide vaccines; proteomics |
| 10/04/2005 | US6951735 Death domain containing receptors |
| 10/04/2005 | US6951723 Detection of ATPase generating microorganisms; obtain microorganismal sample, incubate with substrate, monitor for atpase activity |
| 10/04/2005 | US6951650 Antigenic class of avian reoviruses |
| 10/04/2005 | US6951646 recognizing conformation dependent epitopes of HCV glycoprotein E2 that are capable of neutralizing the binding of E2 protein onto susceptible cells |
| 09/29/2005 | WO2005090553A1 Bacillus subtilis strain having antagonistic activity for controling plant diseases |
| 09/29/2005 | WO2005090384A1 Substances k01-0509 and process for producing the same |
| 09/29/2005 | US20050215619 Pure culture of Pseudomonas putida TX2 (BCRC 910232) with capacity to grow on alkylphenol polyethoxylates or alkylphenols as sole source of carbon and energy; bioremediation of these nonionic surfactants |
| 09/29/2005 | US20050214911 Method for producing L-amino acids by fermentation using bacteria having enhanced expression of xylose utilization genes |
| 09/29/2005 | US20050214909 Genes from a gene cluster |
| 09/29/2005 | US20050214754 Process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis |
| 09/29/2005 | US20050214753 Detection of nucleic acid hybrids |
| 09/29/2005 | US20050214739 Expression of G protein coupled receptors in yeast |
| 09/29/2005 | US20050214324 Culturing avian cells permissive for productive replication of the virus in a serum free medium containing a growth factor or an attachment factor, infecting of the cells with the virus, and cultivating in serum free media until progeny virus is produced |
| 09/29/2005 | US20050214281 G-protein coupled receptor |
| 09/29/2005 | US20050214272 Antiinflammatory agents for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
| 09/29/2005 | US20050214271 for treating airway hyperreactivity and inflammation, atopic dermatitis, allergic conjunctivitis, rhinitis, sinusitis, hypersensitive pneumonia, extrinsic allergic alveolitis, urticaria, eczema, anaphylaxis, angioedema, migraines |
| 09/29/2005 | DE102004062386A1 Monacolin K-Biosynthese-Gene Monacolin K biosynthesis genes |
| 09/29/2005 | CA2538293A1 Substances k01-0509 and process for producing the same |
| 09/28/2005 | EP1580278A1 Process for producing macrolide compound |
| 09/28/2005 | EP1580272A2 TAT transdominant variants of human immunodeficiency virus (HIV) |
| 09/28/2005 | EP1580262A1 Method for producing L-amino acid |
| 09/28/2005 | EP1259622B1 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 09/28/2005 | EP1135486B1 RECOMBINANT SOLUBLE Fc RECEPTORS |
| 09/28/2005 | EP0836646B1 Ocean fish antifreeze peptides as food product additives |
| 09/28/2005 | EP0786006B1 Cephalosporin c amidohydrolase, production and use |
| 09/28/2005 | EP0723593B1 Use of alpha-1,4-glucan lyase for preparation of 1,5-d-anhydrofructose |
| 09/28/2005 | CN1675371A Polypeptides having a- h-a-amino acid amide racemase activity and nucleic acids encoding the same |
| 09/28/2005 | CN1673744A Treatment and diagnosis of cancer |
| 09/28/2005 | CN1220703C Method for stabilising proteins in complex mixtures during thier storage in aqueous solvents |
| 09/27/2005 | US6949626 Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor |
| 09/27/2005 | US6949380 culturing a proliferating epidermal basal cell population, exposing the cell(s) to fetuin, noggin, chordin, gremlin, follistatin, growing the cell(s) in the presence of an antisense oligonucleotide antagonist of bone morphogenetic protein (BMP) |
| 09/27/2005 | US6949366 Complexing; purified polypeptide |
| 09/27/2005 | US6949356 Methods for improving secondary metabolite production in fungi |
| 09/27/2005 | US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections |
| 09/27/2005 | US6949244 produced by hybridoma cell line ATCC No. HB 12020; elicits an immune response against (human milk fat globule) HMFG in non-human primates |
| 09/27/2005 | CA2245680C Method of detection of influenza virus and compounds for use therein |
| 09/27/2005 | CA2149120C Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 09/27/2005 | CA2139670C Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein |
| 09/27/2005 | CA2099612C Monokine mig induced by ifn-gamma |
| 09/22/2005 | WO2005087942A1 Process for expresson of foreign genes in methylotrophic bacteria through chromosomal integration |
| 09/22/2005 | WO2005086670A2 Production of chemicals from lignocellulose, biomass or sugars |
| 09/22/2005 | WO2005060708A3 Canine probiotic lactobacilli |
| 09/22/2005 | US20050209448 Secretion, transcription and sporulation genes in bacillus clauslii |
| 09/22/2005 | US20050208632 Method for producing 2'-deoxyribonucleoside |
| 09/22/2005 | US20050208631 Polypeptide of N-acetylglucosamine-6-O-sulfotransferase and DNA encoding the same |
| 09/22/2005 | US20050208628 Methods and vectors for generating antibodies in avian species and uses therefor |
| 09/22/2005 | US20050208560 Using immunoglobulins to identify staphylococcal peptides associated with viriginiamycin resistant |
| 09/22/2005 | US20050208552 Corpuscles of Stannius protein, stanniocalcin |
| 09/22/2005 | US20050208508 Gene encoding labyrinthin, a marker for cancer |
| 09/22/2005 | US20050208481 Using feline immunedeficiency viral (FIV) envelope protein as screening tool in monoclonal antibody detection |
| 09/22/2005 | US20050208079 Glucan-based vaccines |
| 09/22/2005 | US20050208064 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 09/22/2005 | US20050208053 Administering very late antigen-4, antigen binding fragment thereof, soluble vascular cell adhesion molecule-1 polypeptide; chimera |
| 09/22/2005 | US20050205833 Recombinant peptide |
| 09/21/2005 | EP1577396A1 Method for producing L-amino acids by fermentation using bacteria having enhanced expression of xylose utilization genes |
| 09/21/2005 | EP1577394A1 DNA fragment containing biotin biosynthesis gene and utilization thereof |
| 09/21/2005 | EP1576181A2 Method for detecting microorganisms |
| 09/21/2005 | EP1575881A2 Alanine 2,3- aminomutase |
| 09/21/2005 | EP1212082A4 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 09/21/2005 | EP1204740B1 Methods and compositions for directed cloning and subcloning using homologous recombination |
| 09/21/2005 | EP0974057B1 Methods to detect hk2 polypeptides |
| 09/21/2005 | EP0885310B1 Genetic markers and methods for the detection of escherichia coli serotype-0157:h7 |
| 09/21/2005 | EP0764205B1 Chondroitin lyase enzymes |
| 09/21/2005 | EP0753057B1 Alkaline bacillus amylase |
| 09/21/2005 | EP0752853B1 Human brain phosphodiesterase |
| 09/21/2005 | CN1671840A Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them |
| 09/21/2005 | CN1671838A Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin B12 biosynthesis |
| 09/21/2005 | CN1670217A Process for the preparation of pseudomonic acid A antibiotic by microbiological method |
| 09/21/2005 | CN1670189A Engineering of metabolic control |
| 09/20/2005 | US6946282 Using sulfur dioxide to decrease concentration of carbon dioxide and ethanol produced in industrial steeping process |
| 09/20/2005 | US6946272 Transition state analogs |
| 09/20/2005 | US6946268 Genetically engineered escherichia which has defective cystathionine- beta-lyase and tryptophanase, as well as enhanced serine acetyltransferase activities and accumulates cysteine for use in drugs, cosmetics and foods |
| 09/20/2005 | US6946264 DNA codes for polypeptides having amino acid sequences used as metalloenzyme inhibitors, for prophylaxis of autoimmune diseases or as wound healing agents |
| 09/20/2005 | US6946136 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (HPIV-2) and vaccines based on such virus |
| 09/20/2005 | CA2170606C Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
| 09/15/2005 | WO2005085418A1 Novel lactic acid bacterium |
| 09/15/2005 | US20050202543 Method for producing L-amino acid |
| 09/15/2005 | US20050202540 Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene |
| 09/15/2005 | US20050202529 Humanised antibodies |
| 09/15/2005 | US20050202413 nucleic acid encoding an immunoreactive peptide not recognized by antibodies which are directed against other herpes-viruses for accurate diagnosis; test kits |